{"filing":{"accession_number":"0001104659-26-117844","cik":"0002046386","ticker":"MDLN","company_name":"Medline Inc.","form":"8-K","filing_date":"2026-10-21","report_date":"2026-10-21","primary_document":"tm2627900d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2046386/000110465926117844/tm2627900d1_8k.htm"},"events":[{"id":36776,"run_id":33906,"accession_number":"0001104659-26-117844","anchor_item_number":"7.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"Medline initiated a voluntary field action on October 14, 2026, involving removal and market exit of all Medline Brand beds (homecare, bariatric, long-term care) with estimated costs up to $220 million. While the company states no material impact on FY2026 guidance, the scale of the action (affecting $60M in annual sales, incurring substantial exit costs over 2026-2027) and operational significance of discontinuing an entire product line constitute a material operational event. This is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated operational Item, and does not fit the specific `workforce_reduction` category (which focuses on layoffs and restructuring charges), making `operational_other` the most appropriate classification.","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-10-21","form":"8-K","submitted_at":null,"items":[{"id":41296,"accession_number":"0001104659-26-117844","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Medline initiated a voluntary field action on October 14, 2026, involving removal and market exit of all Medline Brand beds (homecare, bariatric, long-term care) with estimated costs up to $220 million. While the company states no material impact on FY2026 guidance, the scale of the action (affecting $60M in annual sales, incurring substantial exit costs over 2026-2027) and operational significance of discontinuing an entire product line constitute a material operational event. This is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated operational Item, and does not fit the specific `workforce_reduction` category (which focuses on layoffs and restructuring charges), making `operational_other` the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-21T20:35:52.860296+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41296,"accession_number":"0001104659-26-117844","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Medline initiated a voluntary field action on October 14, 2026, involving removal and market exit of all Medline Brand beds (homecare, bariatric, long-term care) with estimated costs up to $220 million. While the company states no material impact on FY2026 guidance, the scale of the action (affecting $60M in annual sales, incurring substantial exit costs over 2026-2027) and operational significance of discontinuing an entire product line constitute a material operational event. This is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated operational Item, and does not fit the specific `workforce_reduction` category (which focuses on layoffs and restructuring charges), making `operational_other` the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-21T20:35:52.860296+00:00","company_name":"Medline Inc.","ticker":"MDLN","filing_date":"2026-10-21"}]}